Annual Gross Profit:
$453.46M+$86.63M(+23.61%)Summary
- As of today, RARE annual gross profit is $453.46 million, with the most recent change of +$86.63 million (+23.61%) on December 31, 2024.
- During the last 3 years, RARE annual gross profit has risen by +$131.30 million (+40.76%).
- RARE annual gross profit is now at all-time high.
Performance
RARE Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Gross Profit:
$131.94M-$2.93M(-2.17%)Summary
- As of today, RARE quarterly gross profit is $131.94 million, with the most recent change of -$2.93 million (-2.17%) on September 30, 2025.
- Over the past year, RARE quarterly gross profit has increased by +$22.23 million (+20.26%).
- RARE quarterly gross profit is now -5.01% below its all-time high of $138.90 million, reached on December 31, 2024.
Performance
RARE Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Gross Profit:
$507.36M+$22.23M(+4.58%)Summary
- As of today, RARE TTM gross profit is $507.36 million, with the most recent change of +$22.23 million (+4.58%) on September 30, 2025.
- Over the past year, RARE TTM gross profit has increased by +$82.97 million (+19.55%).
- RARE TTM gross profit is now at all-time high.
Performance
RARE TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
RARE Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +23.6% | +20.3% | +19.6% |
| 3Y3 Years | +40.8% | +69.0% | +67.9% |
| 5Y5 Years | +426.3% | +73.5% | +156.2% |
RARE Gross Profit Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +41.7% | -5.0% | +69.0% | at high | +67.9% |
| 5Y | 5-Year | at high | +426.3% | -5.0% | +87.3% | at high | +156.2% |
| All-Time | All-Time | at high | >+9999.0% | -5.0% | >+9999.0% | at high | >+9999.0% |
RARE Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $131.94M(-2.2%) | $507.36M(+4.6%) |
| Jun 2025 | - | $134.88M(+32.7%) | $485.13M(+3.9%) |
| Mar 2025 | - | $101.64M(-26.8%) | $467.14M(+4.3%) |
| Dec 2024 | $453.46M(+23.6%) | $138.90M(+26.6%) | $447.96M(+5.6%) |
| Sep 2024 | - | $109.72M(-6.1%) | $424.40M(+5.6%) |
| Jun 2024 | - | $116.88M(+41.8%) | $401.75M(+4.8%) |
| Mar 2024 | - | $82.45M(-28.5%) | $383.26M(-0.3%) |
| Dec 2023 | $366.83M(+14.6%) | $115.34M(+32.5%) | $384.50M(+5.8%) |
| Sep 2023 | - | $87.06M(-11.5%) | $363.33M(+2.5%) |
| Jun 2023 | - | $98.39M(+17.6%) | $354.35M(+6.3%) |
| Mar 2023 | - | $83.70M(-11.1%) | $333.25M(+4.1%) |
| Dec 2022 | $320.01M(-0.7%) | $94.17M(+20.6%) | $319.99M(+5.9%) |
| Sep 2022 | - | $78.08M(+1.0%) | $302.16M(+1.3%) |
| Jun 2022 | - | $77.29M(+9.7%) | $298.34M(-1.1%) |
| Mar 2022 | - | $70.45M(-7.7%) | $301.77M(-6.3%) |
| Dec 2021 | $322.16M(+27.5%) | $76.35M(+2.8%) | $322.16M(-2.0%) |
| Sep 2021 | - | $74.25M(-8.0%) | $328.74M(-0.5%) |
| Jun 2021 | - | $80.72M(-11.1%) | $330.52M(+7.8%) |
| Mar 2021 | - | $90.84M(+9.5%) | $306.52M(+21.3%) |
| Dec 2020 | $252.64M(+193.2%) | $82.93M(+9.1%) | $252.64M(+27.6%) |
| Sep 2020 | - | $76.03M(+34.0%) | $198.03M(+38.5%) |
| Jun 2020 | - | $56.72M(+53.5%) | $142.97M(+33.0%) |
| Mar 2020 | - | $36.96M(+30.5%) | $107.53M(+24.8%) |
| Dec 2019 | $86.17M(+179.7%) | $28.32M(+35.0%) | $86.17M(+21.9%) |
| Sep 2019 | - | $20.97M(-1.4%) | $70.66M(+24.4%) |
| Jun 2019 | - | $21.28M(+36.4%) | $56.82M(+34.9%) |
| Mar 2019 | - | $15.60M(+21.8%) | $42.12M(+36.7%) |
| Dec 2018 | $30.81M | $12.81M(+79.6%) | $30.81M(+72.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $7.13M(+8.6%) | $17.90M(+66.3%) |
| Jun 2018 | - | $6.57M(+53.1%) | $10.76M(+243.2%) |
| Mar 2018 | - | $4.29M(+4349.5%) | $3.14M(+235.3%) |
| Dec 2017 | -$3.21M(>-9900.0%) | -$101.00K(>-9900.0%) | -$2.32M(-4.6%) |
| Sep 2017 | - | $0.00(+100.0%) | -$2.22M(0.0%) |
| Jun 2017 | - | -$1.05M(+9.1%) | -$2.22M(-90.9%) |
| Mar 2017 | - | -$1.16M(>-9900.0%) | -$1.16M(-113.4%) |
| Dec 2016 | $0.00(+100.0%) | $0.00(0.0%) | -$544.00K(+46.9%) |
| Sep 2016 | - | $0.00(0.0%) | -$1.02M(+30.1%) |
| Jun 2016 | - | $0.00(+100.0%) | -$1.47M(+15.2%) |
| Mar 2016 | - | -$544.00K(-13.3%) | -$1.73M(-24.8%) |
| Dec 2015 | -$1.38M(-102.3%) | -$480.00K(-8.8%) | -$1.38M(-24.0%) |
| Sep 2015 | - | -$441.00K(-68.3%) | -$1.12M(-28.4%) |
| Jun 2015 | - | -$262.00K(-30.3%) | -$869.00K(-13.2%) |
| Mar 2015 | - | -$201.00K(+5.2%) | -$768.00K(-12.3%) |
| Dec 2014 | -$684.00K(-54.1%) | -$212.00K(-9.3%) | -$684.00K(-17.1%) |
| Sep 2014 | - | -$194.00K(-20.5%) | -$584.00K(-18.0%) |
| Jun 2014 | - | -$161.00K(-37.6%) | -$495.00K(-48.2%) |
| Mar 2014 | - | -$117.00K(-4.5%) | -$334.00K(+2.1%) |
| Dec 2013 | -$444.00K(-41.9%) | -$112.00K(-6.7%) | -$341.00K(-6.2%) |
| Sep 2013 | - | -$105.00K(>-9900.0%) | -$321.00K(-4.2%) |
| Jun 2013 | - | $0.00(+100.0%) | -$308.00K(0.0%) |
| Mar 2013 | - | -$124.00K(-34.8%) | -$308.00K(-67.4%) |
| Dec 2012 | -$313.00K(-820.6%) | -$92.00K(0.0%) | -$184.00K(-100.0%) |
| Sep 2012 | - | -$92.00K(>-9900.0%) | -$92.00K(>-9900.0%) |
| Jun 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00 | $0.00 |
| Dec 2011 | -$34.00K | - | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual gross profit?
- What is the all-time high annual gross profit for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual gross profit year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly gross profit?
- What is the all-time high quarterly gross profit for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly gross profit year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. TTM gross profit?
- What is the all-time high TTM gross profit for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. TTM gross profit year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual gross profit?
The current annual gross profit of RARE is $453.46M
What is the all-time high annual gross profit for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual gross profit is $453.46M
What is Ultragenyx Pharmaceutical Inc. annual gross profit year-on-year change?
Over the past year, RARE annual gross profit has changed by +$86.63M (+23.61%)
What is Ultragenyx Pharmaceutical Inc. quarterly gross profit?
The current quarterly gross profit of RARE is $131.94M
What is the all-time high quarterly gross profit for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly gross profit is $138.90M
What is Ultragenyx Pharmaceutical Inc. quarterly gross profit year-on-year change?
Over the past year, RARE quarterly gross profit has changed by +$22.23M (+20.26%)
What is Ultragenyx Pharmaceutical Inc. TTM gross profit?
The current TTM gross profit of RARE is $507.36M
What is the all-time high TTM gross profit for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high TTM gross profit is $507.36M
What is Ultragenyx Pharmaceutical Inc. TTM gross profit year-on-year change?
Over the past year, RARE TTM gross profit has changed by +$82.97M (+19.55%)